JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
Jinli Permanent Magnet (06680) announced that the group is expected to achieve a revenue of approximately 3.5 billion yuan in the first half of 2025, which is the same...
Jl Mag Rare-Earth (06680) announced that the group is expected to achieve operating income of approximately 3.5 billion yuan in the first half of 2025, representing a year-on-year growth of 4% to 5%, showing a stable increase in operating income. It is expected that the net profit attributable to the shareholders of the listed company will be between 300 million and 335 million yuan, a year-on-year growth of 151% to 180%; the non-recurring net profit is expected to be around 230 million to 265 million yuan, a year-on-year growth of 576% to 679%.
In the first half of 2025, the company's management actively explored the market and, in the face of uncertain external environment and intensified industry competition, maintained steady development through measures such as technological innovation, organizational optimization, and lean management. The company continues to focus on the field of new energy and energy conservation and environmental protection, focusing on core application areas such as new energy vehicles and automotive components, energy-saving variable frequency air conditioning, wind power generation, Siasun Robot & Automation and industrial servo motors, and 3C, actively cooperating with internationally renowned technology companies in the research and development of Siasun Robot & Automation motor rotors, as well as in the application research and development of low-altitude aircraft, with small batch deliveries scheduled.
In the first half of 2025, non-recurring gains and losses (after tax) were approximately 70 million yuan, compared to 85.67 million yuan in non-recurring gains and losses (after tax) in the same period last year.
Related Articles

HK Stock Market Move | SINOMAB BIO-B(03681) rose more than 18%. The company withdrew the application for the marketing of rituximab for the treatment of RA. The drug has the potential to treat SLE.

HK Stock Market Move | Q TECH (01478) rose by nearly 3% and plans to sell 51% stake in its Indian subsidiary to Dixon from India.

HK Stock Market Move | YOURAN DAIRY (09858) rose more than 7%, institutions are optimistic about the future resonance of the dairy and beef cattle cycles.
HK Stock Market Move | SINOMAB BIO-B(03681) rose more than 18%. The company withdrew the application for the marketing of rituximab for the treatment of RA. The drug has the potential to treat SLE.

HK Stock Market Move | Q TECH (01478) rose by nearly 3% and plans to sell 51% stake in its Indian subsidiary to Dixon from India.

HK Stock Market Move | YOURAN DAIRY (09858) rose more than 7%, institutions are optimistic about the future resonance of the dairy and beef cattle cycles.

RECOMMEND

Jensen Huang Confirms NVIDIA to Begin H20 Chip Shipments to China
15/07/2025

Manus Exits China Market Amid $500 Million Valuation, Prompting Concerns Over AI Agent Sector Outlook
15/07/2025

Trump to Allocate $70 Billion in AI and Energy Investment, Escalating the Race for Technological Dominance
15/07/2025